Search results
Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...
FOX 5 San Diego· 3 hours agoThe data will be presented in a poster at the 2024 American Society...
Milwaukee police pursuit, driver arrested; drugs, 'ghost gun' found
WITI via Yahoo News· 6 days agoSeveral bags were also recovered. One bag had multicolored and multi-shaped pills suspected to be...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 hours ago- Beneficial clinical responses observed with EO2463 monotherapy already at 6 weeks and complete response rate of 78% in patients treated with EO2463 upon addition of lenalidomide ± rituximab - EO2463 rapidly expands memory CD8+ T cells specific
Mercyhealth becomes first U.S. site to enroll stroke patient in clinical study
WIFR Rockford· 2 days agoA Rockford-area hospital becomes the first health center in the continent to participate in a drug...
Salzburg Intensive Care database (SICdb): a detailed exploration and comparative analysis with...
Nature· 4 days agoThe data in the SICdb have been anonymized in accordance with article 4(5) of the European General Data Protection Regulation (GDPR) 28. The database includes data exclusively from ICU patients ...
FDA Clarifies Distinction Between Device Remanufacturing and Servicing in Final Guidance | JD Supra
JD Supra· 2 days agoWhile the US Food and Drug Administration’s recently issued Final Guidance on Remanufacturing of Medical Devices provides clarity and attempts to reign in certain activities ...
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...
Morningstar· 18 hours agoOPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median ...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in...
WTRF Wheeling· 3 days agoFood and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to larsucosterol for the treatment of patients with severe alcohol-associated hepatitis ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoNew Data Underscore the Need for New OSA Treatments That Go Beyond Weight Loss to Address the Neuromuscular Root Cause of the DiseaseOral Presentations include Rationale and Design of SynAIRgy Phase 3 Study for AD109, a Potential Nighttime Oral
NBC 5 Responds finds background check websites often fail to locate criminal records
NBC Chicago· 2 days agoTo help find that reassurance, many turn to online background check companies looking for quick answers. PJ Randhawa of NBC 5 Responds tried three of the most popular consumer background check ...